Amy McBride Wendell, Director at AxoGen, Inc. (AXGN), bought 26,666 shares at $7.50 ($200K) on 2016-10-07, disclosed to the SEC on 2016-10-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.50 | 13,333 | $100K | 50.0% |
| 2 | $7.50 | 13,333 | $100K | 50.0% |
| Total | $7.50 avg | 26,666 | $200K | 100% |
| Filing → |
| SOLV | BUY | 2026-03-11 | $100K | — | Filing → |
| AXGN | SELL | 2025-12-17 | $2.4M | — | Filing → |
| AXGN | SELL | 2025-06-11 | $43K | — | Filing → |